{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:39:31Z","timestamp":1792406371113,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12029-020-00505-w","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T02:02:52Z","timestamp":1599098572000},"page":"899-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Reactive Oxygen Species\u2013Mediated Mitochondrial Dysfunction Triggers Sodium Valproate\u2013Induced Cytotoxicity in Human Colorectal Adenocarcinoma Cells"],"prefix":"10.1007","volume":"52","author":[{"given":"Bondada Venkata Mani","family":"Anirudh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-2383","authenticated-orcid":false,"given":"Devaraj","family":"Ezhilarasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"2","key":"505_CR1","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12029-019-00286-x","volume":"51","author":"M Sohaib","year":"2020","unstructured":"Sohaib M, Ezhilarasan D. Carbamazepine, a histone deacetylase inhibitor induces apoptosis in human colon adenocarcinoma cell line HT-29. J Gastrointest Cancer. 2020;51(2):564\u201370.","journal-title":"J Gastrointest Cancer"},{"issue":"10","key":"505_CR2","first-page":"1656","volume":"4","author":"H Gandomani","year":"2017","unstructured":"Gandomani H, Yousefi S, Aghajani M, Mohammadian-Hafshejani A, Tarazoj A, Pouyesh V, et al. Colorectal cancer in the world: incidence, mortality and risk factors. BMRAT. 2017;4(10):1656\u201375.","journal-title":"BMRAT."},{"issue":"4","key":"505_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut."},{"issue":"3","key":"505_CR4","first-page":"105","volume":"7","author":"AR Marley","year":"2016","unstructured":"Marley AR, Nan H. Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet. 2016;7(3):105\u201314.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"505_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13578-017-0145-7","volume":"7","author":"L Zhang","year":"2017","unstructured":"Zhang L, Song R, Gu D, Zhang X, Yu B, Liu B, et al. The role of GLI1 for 5-Fu resistance in colorectal cancer. Cell Biosci. 2017;7:17.","journal-title":"Cell Biosci"},{"key":"505_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12885-017-3240-6","volume":"17","author":"Y Chen","year":"2017","unstructured":"Chen Y, Wang Y, Shi Y, Dai G. Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: a retrospective study in mFOLFOX6 -treated patients. BMC Cancer. 2017;17:242.","journal-title":"BMC Cancer"},{"issue":"2","key":"505_CR7","first-page":"115","volume":"8","author":"K Metri","year":"2013","unstructured":"Metri K, Bhargav H, Chowdhury P, Koka PS. Ayurveda for chemo-radiotherapy induced side effects in cancer patients. J Stem Cells. 2013;8(2):115\u201329.","journal-title":"J Stem Cells"},{"key":"505_CR8","doi-asserted-by":"crossref","unstructured":"Balagura G, Iapadre G, Verrotti A, Striano P. Moving beyond sodium valproate: choosing the right anti-epileptic drug in children. Expert Opin Pharmacother.\u00a02019;20:1449\u20131456.","DOI":"10.1080\/14656566.2019.1617850"},{"issue":"4","key":"505_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4103\/psychiatry.IndianJPsychiatry_383_18","volume":"61","author":"A Jain","year":"2019","unstructured":"Jain A, Haque I, Tayal V, Roy V. Valproic acid-induced acute pancreatitis. Indian J Psychiatry. 2019;61(4):421\u20132.","journal-title":"Indian J Psychiatry"},{"issue":"39","key":"505_CR10","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276(39):36734\u201341.","journal-title":"J Biol Chem"},{"issue":"1","key":"505_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","volume":"1","author":"S Ropero","year":"2007","unstructured":"Ropero S, Esteller M. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol. 2007;1(1):19\u201325.","journal-title":"Mol Oncol"},{"issue":"9","key":"505_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13(9):673\u201391.","journal-title":"Nat Rev Drug Discov"},{"issue":"28","key":"505_CR13","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2174\/1568026619666181210152115","volume":"18","author":"Y Sun","year":"2018","unstructured":"Sun Y, Sun Y, Yue S, Wang Y, Lu F. Histone deacetylase inhibitors in cancer therapy. Curr Top Med Chem. 2018;18(28):2420\u20138.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"505_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/0973-1482.137937","volume":"10","author":"KC Lakshmaiah","year":"2014","unstructured":"Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther. 2014;10(3):469\u201378.","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"505_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3325\/cmj.2017.58.349","volume":"58","author":"X Ma","year":"2017","unstructured":"Ma X, Wang Y, Gu WP, Zhao X. The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells. Croat Med J. 2017;58(5):349\u201357.","journal-title":"Croat Med J"},{"issue":"1","key":"505_CR16","first-page":"62","volume":"35","author":"XH Tong","year":"2015","unstructured":"Tong XH, Zheng C, Jiang GJ, Dong SY. Sodium valproate enhances doxorubicin cytotoxicity in breast cancer cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(1):62\u20135.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"505_CR17","first-page":"485","volume":"18","author":"S Sargazi","year":"2019","unstructured":"Sargazi S, Saravani R, Zavar Reza J, Jaliani HZ, Mirinejad S, Rezaei Z, et al. Induction of apoptosis and modulation of homologous recombination DNA repair pathway in prostate cancer cells by the combination of AZD2461 and valproic acid. EXCLI J. 2019;18:485\u201398.","journal-title":"EXCLI J"},{"key":"505_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-019-0312-0","volume":"9","author":"H Li","year":"2019","unstructured":"Li H, Zhang Z, Gao C, Wu S, Duan Q, Wu H, et al. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3\/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells. Cell Biosci. 2019;9:50.","journal-title":"Cell Biosci"},{"issue":"9","key":"505_CR19","doi-asserted-by":"publisher","first-page":"15467","DOI":"10.1002\/jcb.28813","volume":"120","author":"O Akgun","year":"2019","unstructured":"Akgun O, Erkisa M, Ari F. Effective and new potent drug combination: histone deacetylase and Wnt\/\u03b2-catenin pathway inhibitors in lung carcinoma cells. J Cell Biochem. 2019;120(9):15467\u201382.","journal-title":"J Cell Biochem"},{"issue":"4","key":"505_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.31557\/APJCP.2019.20.4.1119","volume":"20","author":"M Sanaei","year":"2019","unstructured":"Sanaei M, Kavoosi F. Effect of DNA methyltransferase in comparison to and in combination with histone deacetylase inhibitors on hepatocellular carcinoma HepG2 cell line. Asian Pac J Cancer Prev. 2019;20(4):1119\u201325.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"505_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s12094-016-1494-0","volume":"18","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, You W, Zheng J, Chi Y, Tang W, Du R. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1\u03b1\/VEGF signals. Clin Transl Oncol. 2016;18(11):1123\u201330.","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"505_CR22","first-page":"504","volume":"8","author":"M PonselviInduja","year":"2018","unstructured":"PonselviInduja M, Ezhilarasan D, Ashok Vardhan N. Evolvulus alsinoides methanolic extract triggers apoptosis in HepG2 cells. Avicenna J Phytomed. 2018;8(6):504\u201312.","journal-title":"Avicenna J Phytomed"},{"issue":"6","key":"505_CR23","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/0960327119839173","volume":"38","author":"S Gheena","year":"2019","unstructured":"Gheena S, Ezhilarasan D. Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells. Hum Exp Toxicol. 2019;38(6):694\u2013702.","journal-title":"Hum Exp Toxicol"},{"key":"505_CR24","doi-asserted-by":"publisher","unstructured":"Thakur RS, Devaraj E. Lagerstroemia speciosa (L.) Pers. triggers oxidative stress mediated apoptosis via intrinsic mitochondrial pathway in HepG2 cells. Environ Toxicol. 2020. https:\/\/doi.org\/10.1002\/tox.22987.","DOI":"10.1002\/tox.22987"},{"issue":"7","key":"505_CR25","doi-asserted-by":"publisher","first-page":"11981","DOI":"10.3390\/molecules200711981","volume":"20","author":"J Fan","year":"2015","unstructured":"Fan J, Wang P, Wang X, Tang W, Liu C, Wang Y, et al. Induction of mitochondrial dependent apoptosis in human leukemia K562 cells by Meconopsis integrifolia: a species from traditional Tibetan medicine. Molecules. 2015;20(7):11981\u201393.","journal-title":"Molecules."},{"issue":"1","key":"505_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13046-019-1080-8","volume":"38","author":"L He","year":"2019","unstructured":"He L, Gao L, Shay C, Lang L, Lv F, Teng Y. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. J Exp Clin Cancer Res. 2019;38(1):84.","journal-title":"J Exp Clin Cancer Res"},{"key":"505_CR27","doi-asserted-by":"publisher","first-page":"103184","DOI":"10.1016\/j.bioorg.2019.103184","volume":"91","author":"M Huang","year":"2019","unstructured":"Huang M, Zhang J, Yan C, Li X, Zhang J, Ling R. Small molecule HDAC inhibitors: promising agents for breast cancer treatment. Bioorg Chem. 2019;91:103184.","journal-title":"Bioorg Chem"},{"issue":"9","key":"505_CR28","doi-asserted-by":"publisher","first-page":"E2241","DOI":"10.3390\/ijms20092241","volume":"20","author":"D Banik","year":"2019","unstructured":"Banik D, Moufarrij S, Villagra A. Immunoepigenetics combination therapies: an overview of the role of HDACs in cancer immunotherapy. Int J Mol Sci. 2019;20(9):E2241.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"505_CR29","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1021\/acs.jmedchem.8b00189","volume":"62","author":"Y Luan","year":"2019","unstructured":"Luan Y, Li J, Bernatchez JA, Li R. Kinase and histone deacetylase hybrid inhibitors for cancer therapy. J Med Chem. 2019;62(7):3171\u201383.","journal-title":"J Med Chem"},{"issue":"11","key":"505_CR30","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1002\/cam4.862","volume":"5","author":"N Ibrahim","year":"2016","unstructured":"Ibrahim N, Buchbinder EI, Granter SR, Rodig SJ, Giobbie-Hurder A, Becerra C, et al. A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. Cancer Med. 2016;5(11):3041\u201350.","journal-title":"Cancer Med"},{"key":"505_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2015.04.003","volume":"43","author":"M Duvic","year":"2016","unstructured":"Duvic M, Dimopoulos M. The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: a review of clinical studies. Cancer Treat Rev. 2016;43:58\u201366.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"505_CR32","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10637-015-0252-4","volume":"33","author":"BJ Eigl","year":"2015","unstructured":"Eigl BJ, North S, Winquist E, Finch D, Wood L, Sridhar SS, et al. A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195. Investig New Drugs. 2015;33(4):969\u201376.","journal-title":"Investig New Drugs"},{"key":"505_CR33","first-page":"29","volume":"33","author":"S Sargazi","year":"2019","unstructured":"Sargazi S, Kooshkaki O, Zavar Reza J, Saravani R, Zarei Jaliani H, Mirinejad S, et al. Mild antagonistic effect of valproic acid in combination with AZD2461 in MCF-7 breast cancer cells. Med J Islam Repub Iran. 2019;33:29.","journal-title":"Med J Islam Repub Iran"},{"key":"505_CR34","doi-asserted-by":"publisher","unstructured":"Rithanya P, Ezhilarasan D. Sodium valproate, a histone deacetylase inhibitor, provokes reactive oxygen species-mediated cytotoxicity in human hepatocellular carcinoma cells. J Gastrointest Cancer. 2020. https:\/\/doi.org\/10.1007\/s12029-020-00370-7.","DOI":"10.1007\/s12029-020-00370-7"},{"issue":"2","key":"505_CR35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jop.12806","volume":"48","author":"D Ezhilarasan","year":"2019","unstructured":"Ezhilarasan D, Apoorva VS, Ashok Vardhan N. Syzygium cumini extract induced reactive oxygen species-mediated apoptosis in human oral squamous carcinoma cells. J Oral Pathol Med. 2019;48(2):115\u201321.","journal-title":"J Oral Pathol Med"},{"key":"505_CR36","doi-asserted-by":"crossref","unstructured":"Rohit Singh T, Ezhilarasan D. Ethanolic extract of Lagerstroemia speciosa (L.) Pers., induces apoptosis and cell cycle arrest in HepG2 cells. Nutr Cancer.\u00a02020;72:146\u2013156.","DOI":"10.1080\/01635581.2019.1616780"},{"issue":"3","key":"505_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00280-017-3509-0","volume":"81","author":"N Rivera-Del Valle","year":"2018","unstructured":"Rivera-Del Valle N, Cheng T, Irwin ME, Donnella H, Singh MM, et al. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol. 2018;81(3):483\u201395.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"505_CR38","doi-asserted-by":"publisher","first-page":"E1048","DOI":"10.3390\/ijms18051048","volume":"18","author":"SK Saha","year":"2017","unstructured":"Saha SK, Yin Y, Kim K, Yang GM, Dayem AA, Choi HY, et al. Valproic acid induces endocytosis-mediated doxorubicin internalization and shows synergistic cytotoxic effects in hepatocellular carcinoma cells. Int J Mol Sci. 2017;18(5):E1048.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"505_CR39","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.7314\/APJCP.2013.14.8.4651","volume":"14","author":"CK Wang","year":"2013","unstructured":"Wang CK, Yu XD, Li Q, Xie G, Teng Y. Chloroquine and valproic acid combined treatment in vitro has enhanced cytotoxicity in an osteosarcoma cell line. Asian Pac J Cancer Prev. 2013;14(8):4651\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"505_CR40","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-09-2301","volume":"16","author":"M Koyama","year":"2010","unstructured":"Koyama M, Izutani Y, Goda AE, Matsui TA, Horinaka M, Tomosugi M, et al. Histone deacetylase inhibitors and 15-deoxy-delta12,14-prostaglandin J2 synergistically induce apoptosis. Clin Cancer Res. 2010;16(8):2320\u201332.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"505_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10799893.2018.1468780","volume":"38","author":"A Sudha","year":"2018","unstructured":"Sudha A, Srinivasan P, Kanimozhi V, Palanivel K, Kadalmani B. Antiproliferative and apoptosis-induction studies of 5-hydroxy 3\u2032,4\u2032,7-trimethoxyflavone in human breast cancer cells MCF-7: an in vitro and in silico approach. J Recept Signal Transduct Res. 2018;38(3):179\u201390.","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"505_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13402-017-0366-0","volume":"41","author":"L Wasim","year":"2018","unstructured":"Wasim L, Chopra M. Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells. Cell Oncol (Dordr). 2018;41(2):201\u201312.","journal-title":"Cell Oncol (Dordr)"},{"issue":"4","key":"505_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8(4):603\u201319.","journal-title":"Aging (Albany NY)"},{"key":"505_CR44","doi-asserted-by":"crossref","unstructured":"Ezhilarasan D. Herbal therapy for cancer. In: Srinivasan P, Shanmugam T, editors. Understanding cancer therapies: CRC Press, Boca Raton; 2018. p. 129\u201366.","DOI":"10.1201\/b21957-9"},{"key":"505_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.critrevonc.2017.11.010","volume":"121","author":"SHM Wong","year":"2018","unstructured":"Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC. E-cadherin: its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol. 2018;121:11\u201322.","journal-title":"Crit Rev Oncol Hematol"},{"key":"505_CR46","first-page":"637308","volume":"2014","author":"X Liu","year":"2014","unstructured":"Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308.","journal-title":"Biomed Res Int"},{"issue":"20","key":"505_CR47","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-18-0279","volume":"24","author":"AM Nagle","year":"2018","unstructured":"Nagle AM, Levine KM, Tasdemir N, Scott JA, Burlbaugh K, Kehm J, et al. Loss of E-cadherin enhances IGF1-IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R\/InsR inhibitors. Clin Cancer Res. 2018;24(20):5165\u201377.","journal-title":"Clin Cancer Res"},{"key":"505_CR48","doi-asserted-by":"publisher","first-page":"39630","DOI":"10.1038\/srep39630","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Cheng Y, Zheng Y, He Z, Chen W, Zhou W, et al. PRKAR1A is a functional tumor suppressor inhibiting ERK\/Snail\/E-cadherin pathway in lung adenocarcinoma. Sci Rep. 2016;6:39630.","journal-title":"Sci Rep"},{"issue":"1","key":"505_CR49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12885-017-3829-9","volume":"17","author":"P Zhou","year":"2017","unstructured":"Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1\/NF-\u03baB\/slug\/E-cadherin pathway. BMC Cancer. 2017;17(1):813.","journal-title":"BMC Cancer"},{"issue":"21","key":"505_CR50","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","volume":"27","author":"YI Petrova","year":"2016","unstructured":"Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27(21):3233\u201344.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"505_CR51","first-page":"977","volume":"20","author":"Q Li","year":"2019","unstructured":"Li Q, Zhou X, Fang Z, Pan Z. Effect of STC2 gene silencing on colorectal cancer cells. Mol Med Rep. 2019;20(2):977\u201384.","journal-title":"Mol Med Rep"},{"issue":"6","key":"505_CR52","first-page":"1287","volume":"6","author":"T Singh","year":"2016","unstructured":"Singh T, Prasad R, Katiyar SK. Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression. Am J Cancer Res. 2016;6(6):1287\u2013301.","journal-title":"Am J Cancer Res"},{"issue":"6","key":"505_CR53","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/carcin\/bgt033","volume":"34","author":"SN Vasilatos","year":"2013","unstructured":"Vasilatos SN, Katz TA, Oesterreich S, Wan Y, Davidson NE, Huang Y. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells. Carcinogenesis. 2013;34(6):1196\u2013207.","journal-title":"Carcinogenesis."},{"issue":"3","key":"505_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4161\/onci.18804","volume":"1","author":"AC West","year":"2012","unstructured":"West AC, Christiansen AJ, Smyth MJ, Johnstone RW. The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects. Oncoimmunology. 2012;1(3):377\u20139.","journal-title":"Oncoimmunology."},{"issue":"5","key":"505_CR55","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3892\/ijo.2015.2924","volume":"46","author":"K Yamanegi","year":"2015","unstructured":"Yamanegi K, Kawabe M, Futani H, Nishiura H, Yamada N, Kato-Kogoe N, et al. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells. Int J Oncol. 2015;46(5):1994\u20132002.","journal-title":"Int J Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00505-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:01:49Z","timestamp":1696622509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00505-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00505-w","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"3 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}